Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Pegylated Human Granulocyte Colony-stimulating Factor Injection

Approval Number

国药准字S20210011

Company山东新时代药业有限公司

Registration Date

April 30, 2021

Drug Information

Generic Name

聚乙二醇化重组人粒细胞刺激因子注射液

Dosage Form

注射剂

Strength

1.0ml:3.0mg，活性为2.0*10^8 IU/瓶

Drug Type

生物制品

Registration Date

April 30, 2021

Company Information

Applicant Company

Company Name山东新时代药业有限公司

Company Address

山东费县北外环路1号

Manufacturing Company

Company Name山东新时代药业有限公司

Company Address

山东费县北外环路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

聚乙二醇化重组人粒细胞刺激因子注射液 - NMPA 批准文号 | MedPath